Obsidian Therapeutics
Obsidian Therapeutics is seeking a Research Associate (Contractor) to support discovery and translational research efforts in its Cell Therapy Research Team. The role involves executing in vitro experiments, cellular assays, and data analysis to advance preclinical research objectives for engineered cell and gene therapies. This lab-based position offers the opportunity to work in a collaborative environment while developing expertise in mammalian cell culture and immune cell characterization.
Headquarters
Cambridge, Massachusetts, United States
Obsidian Therapeutics is a clinical-stage biotechnology company using its proprietary cytoDRiVE® platform to engineer novel TIL (tumor-infiltrating lymphocyte) cell therapies. The platform leverages drug-responsive domains (DRDs) to regulate protein function using an FDA-approved small-molecule drug. The company's lead program, OBX-115 (amsoki-cel), is being evaluated in advanced melanoma in a Phase 1/2 clinical trial.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Obsidian Therapeutics.
Scientist, Immuno-Oncology
Systimmune
Senior Scientist
Systimmune
Principal Associate Scientist
Xaira Therapeutics
Senior Associate Scientist - Discovery Research, Regeneron Cell Medicines
Regeneron Pharmaceuticals
Scientist, Cell Therapy Bioscience
AstraZeneca
Principal Scientist – Assay Biology
Syngene International Limited